Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

8 823 evidences · page 202 / 353

92,9 %The sentinel node identification rate improved to 92.9% in the later half of the cases compared to 78.6% in the earlier half, indicating a learning curve.

Nigeriaclinical axillary node-negative breast cancerpublié 2022Nigerian journal of clinical practicePubMeddocument de 8 observations

3 USDThe unit cost per female sex worker reached by STI referrals was 3 USD.

Nigeriasexually transmitted infection (STI)observé 2016publié 2023PloS onePubMeddocument de 10 observations

40,3 %Two hundred and three (40.3%) respondents were aware of the malaria vaccine.

Nigeriapaludismepublié 2023Malaria journalPubMeddocument de 2 observations

442 patientsSouth registered 442 patients with sickle cell disease, representing 5.7% of the total enrolled in Nigeria.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 8 observations

17,3 %The prevalence of severe malaria among admissions was 17.3% in the COVID-19 period.

Nigeriapaludismeobservé 2020publié 2022Impact of COVID-19 on outcomes of childhood severe malaria: A comparative of study pre-COVeurope_pmcdocument de 6 observationsDOI 10.21203/rs.3.rs-2004891/v1

14,8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).

Nigeriatuberculose · VIH/sidapublié 2024BMC public healthPubMeddocument de 4 observations

86,1 %High levels of cadmium were detected in the breast milk of 86.1% of non-diabetic postpartum mothers in Yenagoa.

Nigeriadiabète (non précisé)observé 2020-11-01 to 2021-04-30publié 2023PloS onePubMeddocument de 15 observations

318 patientsThere were 318 breast cancer patients in the institutional database during 2016–2018.

Nigeriacancer du seinobservé 2016-2018publié 2023West African journal of medicinePubMeddocument de 8 observations

17 %17% of HIV-infected patients regressed ≥1 Metavir stage.

NigeriaVIH/sidapublié 2019The Journal of antimicrobial chemotherapyPubMeddocument de 8 observations

10 %The prevalence of anti-HBs among 150 PLHIV in the study was 10%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

46 800 000 individualsThe estimated number of centrally obese adult Nigerians is 46.8 million.

Nigeriacentral obesitypublié 2022Public healthPubMeddocument de 7 observations

8 %Subtype G accounted for 8% of the 1442 HIV-1 pol sequences analysed.

NigeriaVIH/sidaobservé 1999-2014publié 2020Scientific reportsPubMeddocument de 6 observations

35,6 %The proportion of the association between stigma and medication adherence explained through mediation by depression was 35.6%.

Nigeriadépression · VIH/sidaobservé October 2021 to February 2022publié 2024Journal of behavioral medicinePubMeddocument de 4 observations

55 %The prevalence of Plasmodium infection in blood donors in Nigeria was 55%.

NigeriapaludismeHAL · Unilimdocument de 148 observations

31,1 %Disseminated disease was present in 14 (31.1%) patients with AIDS-related Kaposi's sarcoma.

NigeriaAIDS-related Kaposi's sarcomapublié 2022West African journal of medicinePubMeddocument de 10 observations

21,7 %Inflammatory and other conditions of the cervix, which are technically negative smears, accounted for 21.7% of the 161 screened pregnant women.

Nigeriainflammatory and other conditions of the cervixpublié 2021Annals of African medicinePubMeddocument de 7 observations

3 timesThe risk of progression of low-grade cervical intraepithelial neoplasia (CIN1) to high-grade cervical intraepithelial neoplasia (CIN2/3) is 3–5 times higher for women living with HIV than for HIV-negative women.

Nigeriacervical intraepithelial neoplasiapublié 2023PloS onePubMed

33 %Each standard deviation increase in cumulative lifetime endogenous estrogen exposure (CLEEE) was associated with 33% higher breast cancer odds in multivariable models adjusting for BMI and menopausal status.

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations

73,05 utility_scoreThe EQ-5D utility score of people living with HIV/AIDS on antiretroviral therapy in a Nigerian tertiary hospital was 73.05 ± 10.36.

NigeriaVIH/sidapublié 2021Value in health regional issuesPubMeddocument de 4 observations

4,9 clones_per_infectionThe average number of clones per infection in pre-treatment sample was 4.9 with MSP-2.

Nigeriapaludismepublié 2004The American journal of tropical medicine and hygieneeurope_pmcdocument de 6 observationsDOI 10.4269/ajtmh.2004.70.20

Knowledge about 'General Awareness', 'HPV Vaccinations', 'Risk Factors', and 'Symptoms' increased between Phases 2 and 1.

Nigeriacancer du col de l'utéruspublié 2022BMC public healthPubMeddocument de 13 observations

Cervical cancer is the second most common cancer in low- to middle-income countries.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations

58 %The national target for population LLIN ownership in 2016 was 58%.

Nigeriapaludismeobservé 2016publié 2021The Pan African medical journalPubMeddocument de 14 observations

46,16 yearsThe mean age of 154 COVID-19 patients in Nigeria was 46.16 years with a standard deviation of 13.701.

NigeriaCOVID-19observé June to August 30, 2020publié 2020CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF COVID-19 PATIENTS IN LAGOS, NIGERIA: A DESCRIPeurope_pmcdocument de 3 observationsDOI 10.1101/2020.09.15.20195412

3,38 aORFemale sex workers residing in the South East geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 3.38).

NigeriaVIH/sidapublié 2024International journal of STD & AIDSPubMeddocument de 12 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.